SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013718
Filing Date
2020-11-12
Accepted
2020-11-12 16:30:58
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aptx-20200930x10q.htm 10-Q 920961
2 EX-31.1 aptx-20200930ex311e33f41.htm EX-31.1 21896
3 EX-31.2 aptx-20200930ex3127339fa.htm EX-31.2 22059
4 EX-32.1 aptx-20200930ex3211ff99f.htm EX-32.1 10708
5 GRAPHIC aptx-20200930x10q001.jpg GRAPHIC 59444
  Complete submission text file 0001558370-20-013718.txt   4455837

Data Files

Seq Description Document Type Size
6 EX-101.INS aptx-20200930.xml EX-101.INS 1042523
7 EX-101.SCH aptx-20200930.xsd EX-101.SCH 28393
8 EX-101.CAL aptx-20200930_cal.xml EX-101.CAL 32818
9 EX-101.DEF aptx-20200930_def.xml EX-101.DEF 108743
10 EX-101.LAB aptx-20200930_lab.xml EX-101.LAB 257297
11 EX-101.PRE aptx-20200930_pre.xml EX-101.PRE 220180
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38535 | Film No.: 201307224
SIC: 2834 Pharmaceutical Preparations